Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
70 Leser
Artikel bewerten:
(0)

Global Hydrocolloid Dressing Market to Grow at a CAGR of 6.4% by 2021: Companies Focusing on Expansion to Increase Global Distribution Network

DUBLIN, July 17, 2017 /PRNewswire/ --

The "Global Hydrocolloid Dressing Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global hydrocolloid dressing market to grow at a CAGR of 6.48% during the period 2017-2021.

The report, Global Hydrocolloid Dressing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in the market is targeting emerging economies. The companies are focusing on expansion to increase their global distribution network. They have already established their strong foothold in the developed nations. Now the vendors are focusing on emerging nations, which have potential growth options for the vendors.

According to the report, one driver in the market is rising geriatric population. With the increase in older population, the chronic diseases that compromise skin integrity such as peripheral vascular diseases and diabetes are becoming highly common. For example, around 70% of the pressure ulcers occur in the geriatric population. The disease is accompanied by skin breakdown with ulcer and chronic wound formation. The common type of ulcers due to wounds include pressure ulcers, vascular ulcers, and neuropathic ulcers.

Further, the report states that one challenge in the market is unfavorable reimbursement limits. The wound dressings that are eligible for reimbursement have been assigned a code under HCPCS, that corresponds to surgical dressing category. The identification of the category of the dressing is difficult without the code. Sometimes, the wound dressing products that are available in the market do not show to which HCPCS category they belong. If the products do not match the HCPCS code, the reimbursement for those products will not be available.

Key vendors

  • Acelity (KCI Licensing)
  • Coloplast
  • ConvaTec
  • Smith & Nephew

Other prominent vendors

  • 3M
  • BSN medical
  • Hollister Wound Care
  • Lohmann & Rauscher
  • Medline Industries
  • PAUL HARTMANN
  • Roosin Medical

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

PART 09: Decision framework

PART 10: Drivers and challenges

PART 11: Market trends

PART 12: Vendor landscape

PART 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/7vhk3v/global

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.